Phospholipids mediated conversion of HDLs generates specific apoA-II pre-β mobility particles

Journal of Lipid Research

Volumn 50, Issue 4, 2009, Pages 667-675

  Wróblewska, Małgorzata ^a   Kortas Stempak, Barbara ^a   Szutowicz, Andrzej ^a   Badzio, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

A II lipid poor particles; Apolipoprotein A II; High density lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; CHOLESTEROL; EGG YOLK LECITHIN; HIGH DENSITY LIPOPROTEIN; LIPOSOME; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PRE BETA HIGH DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ARTICLE; ELECTROPHORETIC MOBILITY; HUMAN; IMMUNOBLOTTING; IMMUNODETECTION; LIPID ANALYSIS; LIPID METABOLISM; NORMAL HUMAN; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRECIPITATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN LIPID INTERACTION; ANIMAL; IN VITRO STUDY; METABOLISM;

ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; HIGH-DENSITY LIPOPROTEINS, PRE-BETA; HUMANS; LECITHINS; LIPOPROTEINS, HDL; LIPOSOMES; PARTICLE SIZE; PHOSPHOLIPIDS;

EID: 67449124483     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800399-JLR200     Document Type: Article

References (46)

1. Assmann, G., and J. R. Nofer. 2003. Atheroprotective effects of high-density lipoproteins. Annu. Rev. Med. 54: 321-341.
2. Barrans, A., B. Jaspard, R. Barbaras, H. Chap, B. Perret, and X. Collet. 1996. Pre-b HDL: structure and metabolism. Biochim. Biophys. Acta. 1300: 73-85.
3. Cheung, M. C., and J. J. Albers. 1984. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J. Biol. Chem. 259: 12201-12209.
4. Forte, T. M., M. R. McCall, B. B. Knowles, and V. G. Shore. 1989. Isolation and characterization of lipoproteins produced by human hepatoma-derived cell lines other than HepG2. J. Lipid Res. 30: 817-829.
5. Vedhachalam, C., P. T. Duong, M. Nickel, D. Nguyen, P. Dhanasekaran, H. Saito, G. H. Rothblat, S. Lund-Katz, and M. C. Philips. 2007. Mechanism of ATP-binding cassette transporter A1 mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles. J. Biol. Chem. 282: 25123-25130.
6. Matz, C. E., and A. Jonas. 1982. Reaction of human lecithin cholesterol acyltransferase with synthetic micellar complexes of apolipoprotein A-I, phosphatidylcholine, and cholesterol. J. Biol. Chem. 257: 4541-4546.
7. Rye, K. A., M. A. Clay, and P. J. Barter. 1999. Remodelling of high density lipoproteins by plasma factors. Atherosclerosis. 145: 227-238.
8. Liang, H. Q., K. A. Rye, and P. J. Barter. 1995. Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools. Biochim. Biophys. Acta. 1257: 31-37.
9. Bekaert, E. D., P. Alaupovic, C. Knight-Gibson, R. A. Norum, M. J. Laux, and M. Ayrault-Jarrier. 1992. Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasma. Biochim. Biophys. Acta. 1126: 105-113.
10. März, W., and W. Groß. 1988. Immunochemical evidence for the presence in human plasma of lipoproteins with apolipoprotein A-II as the major protein constituent. Biochim. Biophys. Acta. 962: 155-158.
11. Forte, T. M., J. K. Bielicki, R. Goth-Goldstein, J. Selmek, and M. R. McCall. 1995. Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. J. Lipid Res. 36: 148-157.
12. Hara, H., and S. Yokoyama. 1991. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J. Biol. Chem. 266: 3080-3086.
13. Jonas, A., S. A. Sweeny, and P. N. Herbert. 1984. Discoidal complexes of A and C apolipoproteins with lipids and their reactions with lecithin: cholesterol acyltransferase. J. Biol. Chem. 259: 6369-6375.
14. Hime, N. J., K. J. Drew, K. Wee, P. J. Barter, and K. A. Rye. 2006. Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit. J. Lipid Res. 47: 115-122.
15. Clay, M. A., D. H. Pyle, K. A. Rye, and P. J. Barter. 2000. Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin: cholesterol acyltransferase. J. Biol. Chem. 275: 9019-9025.
16. Edelstein, C., M. Halari, and A. M. Scanu. 1982. On the mechanism of the displacement of apolipoprotein A-I by apolipoprotein A-II from the high density lipoprotein surface. Effect of concentration and molecular forms of apolipoprotein A-II. J. Biol. Chem. 257: 7189-7195.
17. Boucher, J., T. A. Ramsamy, S. Braschi, D. Sahoo, T. A. M. Neville, and D. L. Sparks. 2004. Apolipoprotein A-II regulates HDL stability and affects hepatic lipase association and activity. J. Lipid Res. 45: 849-858.
18. Rye, K. A., K. Wee, L. K. Curtiss, D. J. Bonnet, and P. J. Barter. 2003. Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation. J. Biol. Chem. 278: 22530-22536.
19. Ikewaki, K., L. A. Zech, M. Kindt, H. B. Brewer, and D. J. Rader. 1995. Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans. Arterioscler. Thromb. Vasc. Biol. 15: 306-312.
20. Rodrigueza, W. V., K. J. Williams, G. H. Rothblat, and M. C. Philips. 1997. Remodeling and shuttling. Mechanisms for the synergistic effects between different acceptor particles in the mobilization of cellular cholesterol. Arterioscler. Thromb. Vasc. Biol. 17: 383-393.
21. Jian, B., M. de la Llera-Moya, L. Royer, G. Rothblat, O. Francone, and J. B. Swaney. 1997. Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid. J. Lipid Res. 38: 734-744.
22. Hassan, H. H, S. Blain, B. Boucher, M. Denis, L. Krimbou, and J. Genest. 2005. Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release. J. Lipid Res. 46: 1457-1465.
23. Guo, L. S. S., R. L. Hamilton, J. Goerke, J. N. Weinstein, and R. J. Havel. 1980. Interaction of unilamellar liposomes with serum lipoproteins and apolipoproteins. J. Lipid Res. 21: 993-1003.
24. Tall, A. R., and P. H. R. Green. 1981. Incorporation of phosphatidylcholine into spherical and discoidal lipoproteins during incubation of egg phosphatidylcholine vesicles with isolated high density lipoproteins or with plasma. J. Biol. Chem. 256: 2035-2044.
25. Burstein, M., H. R. Scholnick, and R. Morfin. 1970. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res. 11: 583-595.
26. Kim, Y. C., and T. Nishida. 1977. Nature of interaction of dextran sulfate with lecithin dispersions and lysolecithin micelles. J. Biol. Chem. 252: 1243-1249.
27. 2+. J. Biol. Chem. 254: 9621-9626.
28. Brousseau, T., V. Clavey, J. M. Bard, and J. C. Fruchart. 1993. Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins, and lipoprotein particles. Clin. Chem. 39: 960-964.
29. 3H]cholesterol on values of esterification rate of cholesterol in apolipoprotein B-depleted plasma. J. Lipid Res. 41: 1356-1357.
30. Asztalos, B. F., C. H. Sloop, L. Wong, and P. S. Roheim. 1993. Two dimensional electrophoresis of plasma lipoproteins: recognition of new apoA-I-containing subpopulations. Biochim. Biophys. Acta. 1169: 291-300.
31. Nichols, A. V., E. L. Gong, P. J. Blanche, and T. M. Forte. 1983. Characterization of discoidal complexes of phosphatidylcholine, apolipoprotein A-I and cholesterol by gradient gel electrophoresis. Biochim. Biophys. Acta. 750: 353-364.
32. Van Tornout, P., R. Vercaemst, M. J. Lievens, H. Caster, M. Rosseneu, and G. Assmann. 1980. Reassembly of human apoproteins A-I and A-II with unilamellar phosphatidylcholine-cholesterol liposomes. Association kinetics and characterization of the complexes. Biochim. Biophys. Acta. 601: 509-523.
33. Pownall, H. J., J. B. Massey, S. K. Kusserow, and A. M. Gotto, Jr. 1978. Kinetics of lipid-protein interactions: effect of cholesterol on the association of human plasma high density apolipoprotein A-I with L-α dimyristoylphosphatidylcholine. Biochemistry. 17: 1183-1188.
34. Swaney, J. B., and E. Palmieri. 1984. Hybrid association between human apolipoproteins A-I and A-II in aqueous solution and in phospholipid recombinants. Biochim. Biophys. Acta. 792: 164-171.
35. Blanche, P. J., A. V. Nichols, T. M. Forte, and E. L. Gong. 1988. Characterization of complexes of egg yolk phosphatidylcholine and apolipoprotein A-II prepared in the absence and presence of sodium cholate. Biochim. Biophys. Acta. 958: 143-152.
36. Clay, M. A., D. A. Cehic, D. H. Pyle, K. A. Rye, and P. J. Barter. 1999. Formation of apolipoprotein specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II. Biochem. J. 337: 445-451.
37. Davidson, W. S., D. L. Sparks, S. Lund-Katz, and M. C. Phillips. 1994. The molecular basis for the difference in charge between pre-β - and α-migrating high density lipoproteins. J. Biol. Chem. 269: 8959-8965.
38. Huuskonen, J., V. M. Olkkonen, M. Jauhiainen, and C. Ehnholm. 2001. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis. 155: 269-281.
39. Musliner, T. A., H. J. Michenfelder, and R. M. Krauss. 1988. Interactions of high density lipoproteins with very low and low density lipoproteins during lipolysis. J. Lipid Res. 29: 349-361.
40. Castellani, L. W., C. N. Nguyen, S. Charugundla, M. W. Weinstein, C. X. Doan, W. S. Blaner, N. Wongsiriroj, and A. L. Lusis. 2008. Apolipoprotein A-II is a regulator of VLDL metabolism and insulin resistance. J. Biol. Chem. 283: 11633-11644.
41. Pastier, D., S. Dugué, E. Boisfer, V. Atger, N. Q. Tran, A. van Tol, M. J. Chapman, J. Chambaz, P. M. Laplaud, and A. D. Kalopissis. 2001. Apolipoprotein A-II/A-I ratio is a key determinant in vivo of HDL concentration and formation of pre-β HDL containing apolipoprotein A-II. Biochemistry. 40: 12243-12253.
42. Fournier, N., A. Cogny, V. Atger, D. Pastier, D. Goudouneche, A. Nicoletti, N. Moatti, J. Chambaz, J. L. Paul, and A. D. Kalopissis. 2002. Opposite effects of plasma from human apolipoprotein A-II transgenic mice on cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells. Arterioscler. Thromb. Vasc. Biol. 22: 638-643.
43. Fitzgerald, M. L., A. L. Morris, A. Chroni, A. J. Mendez, V. I. Zannis, and M. W. Freeman. 2004. ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux. J. Lipid Res. 45: 287-294.
44. Warden, C. H., C. C. Hedrick, J. H. Qiao, L. W. Castellani, and A. J. Lusis. 1993. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 261: 469-472.
45. Birjmohun, R. S., G. M. Dallinga-Thie, J. A. Kuivenhoven, E. S. G. Stroes, J. D. Otvos, N. J. Wareham, R. Luben, J. J. P. Kastelein, K. T. Khaw, and S. M. Boekholdt. 2007. Apolipoprotein A-II is inversely associated with risk of future coronary artery disease. Circulation. 116: 2029-2035.
46. Dugué-Pujol, S., X. Rousset, D. Château, D. Pastier, C. Klein, J. Demeurie, C. Cywiner-Golenzer, M. Chabert, P. Verroust, J. Chambaz, et al. 2007. Apolipoprotein A-II is catabolized in the kidney as a function of its plasma concentration. J. Lipid Res. 48: 2151-2161.